Consistent with a hypothesis of compensatory downregulation of EZH2 in early prostate tumorigenesis, the positive correlation between INPP4B and EZH2 is only evident in the primary prostate tumors (Figure 2e). This evidence concerns the gene INPP4B and prostate neoplasm.